Business Context and Reporting Period
This Form 8-K was filed by WellPoint, Inc. (now Elevance Health, Inc.) on January 7, 2014. The report discloses the company's agreements to sell its vision care businesses, 1-800 CONTACTS and glasses.com.
Key Financial Metrics
- Impairment Charge: Expected to record a charge in the range of $0.52 to $0.57 per share in the fourth quarter of 2013 related to the asset sales.
- Full Year 2013 GAAP Net Income Guidance: At least $7.88 per share.
- Full Year 2013 Adjusted Net Income Guidance: At least $8.40 per share (excluding the impairment charge).
- Investment Gains/Losses: Guidance assumes no investment gains or losses beyond those recorded in the first nine months of 2013.
Material Changes
The primary material change is the strategic divestiture of the 1-800 CONTACTS and glasses.com businesses. This transaction necessitates a downward revision to the full-year 2013 GAAP earnings guidance due to the anticipated impairment charge, while adjusted earnings guidance remains stable.
Outlook and Management Commentary
Management indicated that the sale agreements are finalized. The company provided updated full-year 2013 earnings guidance reflecting the impact of the divestiture. The filing notes that the press release containing the GAAP reconciliation for adjusted net income is included as Exhibit 99.1.
Investor Verification Checklist
- Verify the final sale price and closing date for 1-800 CONTACTS and glasses.com.
- Confirm the exact impairment charge amount recorded in the Q4 2013 financial statements.
- Review the GAAP reconciliation for adjusted net income per share in the referenced press release (Exhibit 99.1).
- Assess the impact of the divestiture on future revenue streams and operating margins.